CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 46 filers reported holding CASI PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $23,000 | 0.0% | 28,703 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | -32.4% | 28,703 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $34,000 | -22.7% | 28,703 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $44,000 | -36.2% | 28,703 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $69,000 | -18.8% | 28,703 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $85,000 | +93.2% | 28,703 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $44,000 | -36.2% | 28,703 | +4.1% | 0.00% | -50.0% |
| Q2 2020 | $69,000 | +81.6% | 27,585 | +48.5% | 0.00% | +33.3% |
| Q1 2020 | $38,000 | +22.6% | 18,579 | +84.0% | 0.00% | +50.0% |
| Q4 2019 | $31,000 | -8.8% | 10,095 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $34,000 | +6.2% | 10,095 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $32,000 | +10.3% | 10,095 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $29,000 | – | 10,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IDG-Accel China Growth Fund III Associates L.P. | 7,973,536 | $23,522,000 | 27.18% |
| Consonance Capital Management LP | 7,576,431 | $22,350,000 | 2.09% |
| Wellington Shields & Co., LLC | 1,812,769 | $5,348,000 | 1.92% |
| Wellington Shields Capital Management, LLC | 2,071,765 | $6,112,000 | 0.82% |
| Ikarian Capital, LLC | 1,268,154 | $3,741,000 | 0.16% |
| Sio Capital Management, LLC | 203,432 | $600,000 | 0.12% |
| Zebra Capital Management LLC | 11,182 | $33,000 | 0.04% |
| FEDERATED HERMES, INC. | 7,000,000 | $20,650,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,146 | $154,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 161,949 | $478,000 | 0.02% |